ClearBridge Investments
PCVX icon

ClearBridge Investments’s Vaxcyte PCVX Stock Holding History

ClearBridge Investments’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.46M Buy
+128,377
New +$6.97M 0.01% 504
2025
Q3 		– Sell
-646,055
Closed -$21M – 742
2025
Q2 		$21M Sell
646,055
-574,400
-47% -$18.8M 0.02% 411
2025
Q1 		$46.1M Buy
1,220,455
+117,969
+11% +$9.43M 0.04% 317
2024
Q4 		$90.2M Sell
1,102,486
-56,794
-5% -$5.64M 0.07% 242
2024
Q3 		$132M Buy
1,159,280
+973,139
+523% +$87.7M 0.1% 191
2024
Q2 		$14.1M Buy
+186,141
New +$12.7M 0.01% 495

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return